Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (9710)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Mar 7, 2021 (publication date) through Feb 15, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Xiang TD, Zheng X. Interaction between hepatitis B virus and SARS-CoV-2 infections. World J Gastroenterol 2021; 27(9): 782-793 [PMID: 33727770 DOI: 10.3748/wjg.v27.i9.782] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v27/i9/782.htm |
| Number | Citing Articles |
| 1 |
Ryunjin Lee, Jiwan Choi, Eunkyeong Lee, Jooyoung Lee, Jiye Kim, Seoon Kang, Hye-In An, Sung-Han Kim, Sung-Min Kim, Eun-Kyoung Jwa, Gil-Chun Park, Jung-Man Namgoong, Gi-Won Song, Young-In Yoon, Eunyoung Tak, Sung-Gyu Lee. Effects of combined immunosuppressant and hepatitis B virus antiviral use on COVID-19 vaccination in recipients of living donor liver transplantation. PeerJ 2024; 12: e18651 doi: 10.7717/peerj.18651
|
| 2 |
Antonio Mastroianni, Sonia Greco, Luciana Chidichimo, Maria Vittoria Mauro, Filippo Urso, Valeria Vangeli. Antiviral prophylaxis for hepatitis B virus in COVID-19 patients treated with immunosuppressive drug therapy. Antiviral Therapy 2022; 27(2) doi: 10.1177/13596535211067602
|
| 3 |
Xiu‐He Lv, Jin‐Lin Yang, Kai Deng. Letter to the Editor: Unanswered questions about hepatitis B virus infection in patients with COVID‐19. Hepatology 2022; 75(1): 229 doi: 10.1002/hep.32098
|
| 4 |
Lucio Boglione, Maria Grazia Crobu, Mario Pirisi, Carlo Smirne. Clinical Characteristics and Outcomes in Patients with Chronic HBV Infection and Hospitalized for COVID-19 Pneumonia: A Retrospective Cohort Study. Viruses 2024; 17(1): 40 doi: 10.3390/v17010040
|
| 5 |
Babak Sokouti. A systems biology approach for investigating significantly expressed genes among COVID-19, hepatocellular carcinoma, and chronic hepatitis B. Egyptian Journal of Medical Human Genetics 2022; 23(1) doi: 10.1186/s43042-022-00360-3
|
| 6 |
M. V. Kruchinina, N. E. Pershina, I. O. Svetlova, E. V. Kruchinina. Factors affecting the development of liver fibrosis in patients who experienced COVID-19. Bulletin of Siberian Medicine 2023; 22(2): 134 doi: 10.20538/1682-0363-2023-2-134-144
|
| 7 |
Chang Gao, Jingjing Ni, Ye Gao, Dan Xie, Lijuan Yang, Bining Yang, Xiaoting Lu, Qiang Guo. Association of current hepatitis B virus infection with mortality in adults with sepsis. Epidemiology and Infection 2023; 151 doi: 10.1017/S0950268823000729
|
| 8 |
Shewafera Wondimagegnhu Teklu. Impacts of optimal control strategies on the HBV and COVID-19 co-epidemic spreading dynamics. Scientific Reports 2024; 14(1) doi: 10.1038/s41598-024-55111-8
|
| 9 |
Malihe Naderi, Seyed Masoud Hosseini, Naser Behnampour, Iraj Shahramian, Abdolvahab Moradi. Impact of COVID-19 in Chronic Viral Hepatitis B Patients on Virological, Clinical, and Paraclinical Aspects. Jundishapur Journal of Microbiology 2022; 15(6) doi: 10.5812/jjm-127312
|
| 10 |
Liqing Wang, Hao-Yun Peng, Aspen Pham, Eber Villazana, Darby J. Ballard, Jugal Kishore Das, Anil Kumar, Xiaofang Xiong, Jianxun Song. T Cell Response to SARS-CoV-2 Coinfection and Comorbidities. Pathogens 2023; 12(2): 321 doi: 10.3390/pathogens12020321
|
| 11 |
Laith A. I. K. Al-Kaif, Mohammad Abd-Kadhum Al-Saadi, Alaa H. Al-Charrakh. Effect of SARS-CoV-2 Infection on HBV-Infected Patients. Medical Journal of Babylon 2022; 19(4): 736 doi: 10.4103/MJBL.MJBL_248_22
|
| 12 |
Sheng-Han Wang, Shiou-Hwei Yeh, Pei-Jer Chen. Unique Features of Hepatitis B Virus-Related Hepatocellular Carcinoma in Pathogenesis and Clinical Significance. Cancers 2021; 13(10): 2454 doi: 10.3390/cancers13102454
|
| 13 |
Md Arju Hossain, Md Habibur Rahman, Habiba Sultana, Asif Ahsan, Saiful Islam Rayhan, Md Imran Hasan, Md Sohel, Pratul Dipta Somadder, Mohammad Ali Moni. An integrated in-silico Pharmaco-BioInformatics approaches to identify synergistic effects of COVID-19 to HIV patients. Computers in Biology and Medicine 2023; 155: 106656 doi: 10.1016/j.compbiomed.2023.106656
|
| 14 |
Shewafera Wondimagegnhu Teklu, D. Easwaramoorthy. Analysis of HBV and COVID‐19 Coinfection Model with Intervention Strategies. Computational and Mathematical Methods in Medicine 2023; 2023(1) doi: 10.1155/2023/6908757
|
| 15 |
Tong Sun, Hongbo Chi, Jing Wang, Yufen Zheng, Hongguo Zhu, Jingxian Zhao, Kai Zhou, Mengyuan Chen, Donglian Wang, Tao-Hsin Tung, Jiaqin Xu, Bo Shen. Effect of SARS-CoV-2 infection on liver function in patients with hepatitis B. BMC Infectious Diseases 2024; 24(1) doi: 10.1186/s12879-024-10324-0
|
| 16 |
Shanshan Yang, Shengshu Wang, Mingmei Du, Miao Liu, Yunxi Liu, Yao He. Patients with COVID-19 and HBV Coinfection are at Risk of Poor Prognosis. SSRN Electronic Journal 2021; doi: 10.2139/ssrn.3929974
|
| 17 |
Cyriac Abby Philips, Deepak Madhu, Philip Augustine. Investigating the correlation between COVID-19 and the progression of chronic liver disease. Expert Review of Gastroenterology & Hepatology 2023; 17(6): 603 doi: 10.1080/17474124.2023.2206564
|
| 18 |
Shahrzad Shoraka, Seyed Reza Mohebbi, Seyed Masoud Hosseini, Amir Ghaemi, Mohammad Reza Zali. SARS-CoV-2 and chronic hepatitis B: Focusing on the possible consequences of co-infection. Journal of Clinical Virology Plus 2023; 3(4): 100167 doi: 10.1016/j.jcvp.2023.100167
|
| 19 |
Wen-Shu Hu, Fang-Ying Jiang, Wen Shu, Rong Zhao, Ji-Min Cao, De-Ping Wang. Liver injury in COVID-19: A minireview. World Journal of Gastroenterology 2022; 28(47): 6716-6731 doi: 10.3748/wjg.v28.i47.6716
|
| 20 |
D. Krenytska, A. Rachkovska, O. Savchuk, V. Karbovskiy. Biochemical parameters of the functional state liver in patients with hepatitis Under conditions of SARS-CoV-2 coinfection. Bulletin of Taras Shevchenko National University of Kyiv. Series: Biology 2021; (87): 12 doi: 10.17721/1728.2748.2021.87.12-17
|
| 21 |
Levente Zsichla, Viktor Müller. Risk Factors of Severe COVID-19: A Review of Host, Viral and Environmental Factors. Viruses 2023; 15(1): 175 doi: 10.3390/v15010175
|
| 22 |
Muhammed Bekçibaşı, Eyüp Arslan. Severe acute respiratory syndrome coronavirus 2 (SARS‐COV‐2) /Hepatitis B virus (HBV) Co‐infected Patients: A case series and review of the literature. International Journal of Clinical Practice 2021; 75(9) doi: 10.1111/ijcp.14412
|
| 23 |
Peipei Wang, Junjian Chen, Dabiao Chen, Ziying Lei, Zhishuo Mo, Ying Zhang. Patients with chronic hepatitis B under nucleos(t)ide analog therapy with Omicron BA.5 infection: A retrospective study in South China. Liver Research 2024; doi: 10.1016/j.livres.2024.11.003
|
| 24 |
Mariem Gdoura, Raoua Touati, Sana Kalthoum, Rania Ben Slama, Nouel Fatnassi, Mehdi Mrad, Lamia Ammari, Nozha Brahmi, Amira Ben Jazia, Nahed Hogga, Henda Triki, Sondes Haddad-Boubaker. Presumed Protective Role for Anti-Hepatitis B Virus Antibodies Against COVID-19 Severe Cases: A Clinical Study Confirming in silico Hypothesis. Frontiers in Medicine 2022; 9 doi: 10.3389/fmed.2022.909660
|
| 25 |
Parisa S. Aghbash, Narges Eslami, Milad Shirvaliloo, Hossein B. Baghi. Viral coinfections in COVID‐19. Journal of Medical Virology 2021; 93(9): 5310 doi: 10.1002/jmv.27102
|
| 26 |
Nicolò Brandi, Daniele Spinelli, Alessandro Granito, Francesco Tovoli, Fabio Piscaglia, Rita Golfieri, Matteo Renzulli. COVID-19: Has the Liver Been Spared?. International Journal of Molecular Sciences 2023; 24(2): 1091 doi: 10.3390/ijms24021091
|
| 27 |
Yanting Du, Chen Wang, Ying Zhang. Viral Coinfections. Viruses 2022; 14(12): 2645 doi: 10.3390/v14122645
|
| 28 |
Shanshan Yang, Shengshu Wang, Mingmei Du, Miao Liu, Yunxi Liu, Yao He. Patients with COVID-19 and HBV Coinfection are at Risk of Poor Prognosis. Infectious Diseases and Therapy 2022; 11(3): 1229 doi: 10.1007/s40121-022-00638-4
|